207 related articles for article (PubMed ID: 27934159)
21. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
[TBL] [Abstract][Full Text] [Related]
22. Site-Specific
Lumen D; Näkki S; Imlimthan S; Lambidis E; Sarparanta M; Xu W; Lehto VP; Airaksinen AJ
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31861119
[TBL] [Abstract][Full Text] [Related]
23. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
Peracchia MT; Fattal E; Desmaële D; Besnard M; Noël JP; Gomis JM; Appel M; d'Angelo J; Couvreur P
J Control Release; 1999 Jun; 60(1):121-8. PubMed ID: 10370176
[TBL] [Abstract][Full Text] [Related]
24. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
Su G; Jiang H; Xu B; Yu Y; Chen X
Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
[TBL] [Abstract][Full Text] [Related]
25. Cell-Conditioned Protein Coronas on Engineered Particles Influence Immune Responses.
Dai Q; Guo J; Yan Y; Ang CS; Bertleff-Zieschang N; Caruso F
Biomacromolecules; 2017 Feb; 18(2):431-439. PubMed ID: 28075126
[TBL] [Abstract][Full Text] [Related]
26. Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh JY; Kim HS; Palanikumar L; Go EM; Jana B; Park SA; Kim HY; Kim K; Seo JK; Kwak SK; Kim C; Kang S; Ryu JH
Nat Commun; 2018 Oct; 9(1):4548. PubMed ID: 30382085
[TBL] [Abstract][Full Text] [Related]
27. The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms.
Yang Y; Neef T; Mittelholzer C; Garcia Garayoa E; Bläuenstein P; Schibli R; Aebi U; Burkhard P
J Nanobiotechnology; 2013 Nov; 11():36. PubMed ID: 24219600
[TBL] [Abstract][Full Text] [Related]
28. Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona.
Sakulkhu U; Mahmoudi M; Maurizi L; Coullerez G; Hofmann-Amtenbrink M; Vries M; Motazacker M; Rezaee F; Hofmann H
Biomater Sci; 2015 Feb; 3(2):265-78. PubMed ID: 26218117
[TBL] [Abstract][Full Text] [Related]
29. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional NaYF4:Yb, Er@mSiO2@Fe3O4-PEG nanoparticles for UCL/MR bioimaging and magnetically targeted drug delivery.
Liu B; Li C; Ma P; Chen Y; Zhang Y; Hou Z; Huang S; Lin J
Nanoscale; 2015 Feb; 7(5):1839-48. PubMed ID: 25521795
[TBL] [Abstract][Full Text] [Related]
31. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles.
Sharma A; Cornejo C; Mihalic J; Geyh A; Bordelon DE; Korangath P; Westphal F; Gruettner C; Ivkov R
Sci Rep; 2018 Mar; 8(1):4916. PubMed ID: 29559734
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics.
Bertrand N; Grenier P; Mahmoudi M; Lima EM; Appel EA; Dormont F; Lim JM; Karnik R; Langer R; Farokhzad OC
Nat Commun; 2017 Oct; 8(1):777. PubMed ID: 28974673
[TBL] [Abstract][Full Text] [Related]
33. PEGylation of Carbonate Apatite Nanoparticles Prevents Opsonin Binding and Enhances Tumor Accumulation of Gemcitabine.
Mozar FS; Chowdhury EH
J Pharm Sci; 2018 Sep; 107(9):2497-2508. PubMed ID: 29883662
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and dose interval dependent hepatotoxicity evaluation of intravenously administered polyethylene glycol-8000 coated ultra-small superparamagnetic iron oxide nanoparticle on Wistar rats.
Rajan B; Sathish S; Balakumar S; Devaki T
Environ Toxicol Pharmacol; 2015 Mar; 39(2):727-35. PubMed ID: 25721486
[TBL] [Abstract][Full Text] [Related]
35. The One Year Fate of Iron Oxide Coated Gold Nanoparticles in Mice.
Kolosnjaj-Tabi J; Javed Y; Lartigue L; Volatron J; Elgrabli D; Marangon I; Pugliese G; Caron B; Figuerola A; Luciani N; Pellegrino T; Alloyeau D; Gazeau F
ACS Nano; 2015 Aug; 9(8):7925-39. PubMed ID: 26168364
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.
Bimbo LM; Sarparanta M; Santos HA; Airaksinen AJ; Mäkilä E; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J; Salonen J
ACS Nano; 2010 Jun; 4(6):3023-32. PubMed ID: 20509673
[TBL] [Abstract][Full Text] [Related]
37. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
38. In Vitro and In Vivo Evaluation of PEGylated Layer-by-Layer Polyelectrolyte-Coated Paclitaxel Nanocrystals.
Polomska A; Gauthier MA; Leroux JC
Small; 2017 Jan; 13(2):. PubMed ID: 27748999
[TBL] [Abstract][Full Text] [Related]
39. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
40. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
